Evidence map›Paper›PMID 31344978›Full record

ArticleInternational journal of molecular sciences2019

New Aspects Towards a Molecular Understanding of the Allicin Immunostimulatory Mechanism via Colec12, MARCO, and SCARB1 Receptors.

Vlad Al Toma, Adrian Bogdan Tigu, Anca D Farcaș, Bogdan Sevastre, Marian Taulescu, Ana Maria Raluca Gherman, Ioana Roman, Eva Fischer-Fodor, Marcel Pârvu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Phytochemical Analysis and In Vitro Effects ofMolecules (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Vlad Al TomaFaculty of Biology and Geology, Department of Molecular Biology and Biotechnologies, Babeș-Bolyai University, 400028 Cluj-Napoca, Romania. vlad.al.toma@gmail.com.
Adrian Bogdan TiguFaculty of Biology and Geology, Department of Molecular Biology and Biotechnologies, Babeș-Bolyai University, 400028 Cluj-Napoca, Romania.
Anca D FarcașFaculty of Biology and Geology, Department of Molecular Biology and Biotechnologies, Babeș-Bolyai University, 400028 Cluj-Napoca, Romania.
Bogdan SevastreFaculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania.
Marian TaulescuFaculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine, 400372 Cluj-Napoca, Romania.ORCID 0000-0002-8987-6038
Ana Maria Raluca GhermanDepartment of Molecular and Biomolecular Physics, National Institute for R&D of Isotopic and Molecular Technologies, 67-103 Donat, 400293 Cluj-Napoca, Romania.
Ioana RomanInstitute of Biological Research Cluj-Napoca, branch of NIRDBS Bucureşti, 400113 Cluj-Napoca, Romania.ORCID 0000-0001-8002-8035
Eva Fischer-Fodor"Medfuture"-Research Centre for Advanced Medicine, University of Medicine and Pharmacy "Iuliu Haţieganu" 400349 Cluj-Napoca, Romania.ORCID 0000-0002-0898-0547
Marcel PârvuFaculty of Biology and Geology, Department of Molecular Biology and Biotechnologies, Babeș-Bolyai University, 400028 Cluj-Napoca, Romania.ORCID 0000-0002-5892-9280
Babeș-Bolyai University · ROIuliu Hațieganu University of Medicine and Pharmacy · ROUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RONational Institute of Research and Development for Biological Sciences · RO

Funding

National Authority for Scientific Research and Innovation IZO-MOL-EA PN19 35 02 03
6 · The paper itself

Abstract

The allicin pleiotropic effects, which include anti-inflammatory, anti-oxidant, anti-tumoral, and antibacterial actions, were well demonstrated and correlated with various molecular pathways. The immunostimulatory mechanism of allicin has not been elucidated; however, there is a possible cytokine stimulation from immunoglobulin release caused by allicin. In this study, when Wistar female rats and CD19+ lymphocytes were treated with three different doses of allicin, immunoglobulins, glutathione, and oxidative stress markers were assayed. Molecular docking was performed between S-allylmercaptoglutathione (GSSA)-a circulating form of allicin in in vivo systems formed by the allicin interaction with glutathione (GSH)-and scavenger receptors class A and B from macrophages, as well as CD19+ B lymphocytes. Our data demonstrated a humoral immunostimulatory effect of allicin in rats and direct stimulation of B lymphocytes by S-allyl-mercapto-glutathione, both correlated with decreased catalase (CAT) activity. The molecular docking revealed that S-allyl-mercapto-glutathione interacting with Colec12, MARCO (class A), and SCARB1 (class B) scavenger receptors in in vitro tests demonstrates a direct stimulation of immunoglobulin secretion by GSSA in CD19+ B lymphocytes. These data collectively indicate that GSSA stimulates immunoglobulin secretion by binding on scavenger receptors class B type 1 (SCARB1) from CD19+ B lymphocytes.

Indexed as

AnimalsAnti-Bacterial AgentsAntigens, CD19Anti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsCatalaseCollectinsDisulfidesGlutathioneHumansImmunizationLymphocytesMacrophagesMolecular Docking SimulationOxidative StressallicinAnti-Bacterial AgentsAntigens, CD19Anti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsCatalaseCOLEC12 protein, ratCollectinsDisulfidesGlutathioneMARCO protein, ratReceptors, ImmunologicReceptors, ScavengerScarb1 protein, ratScavenger Receptors, Class BSulfinic Acidsallicinimmunoglobulinsmechanismscavenger receptors

Identifiers

PMID31344978
PMCPMC6696194
OpenAlexW2963479320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.